UNSPSC 51314329: Carbetapentane/chlorpheniramine/ephedrine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE502. This VA Drug Class (RE502) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/ANTITUSSIVE.

UNSPSC 51314329 Carbetapentane/chlorpheniramine/ephedrine/phenylephrine is a Commodity code that in practice captures state and local procurement of pharmaceuticals and over-the-counter health products across therapeutic categories and delivery models, rather than tracking this single branded combination agent in isolation. Recent state and local solicitations under the code reflect procurement of generic multi-source pharmaceuticals, naloxone and drug deactivation systems, and direct-to-manufacturer prescription programs. Issuing bodies span county health departments, state health and human services agencies, and multistate cooperative purchasing alliances; Seminole County, Florida and the Minnesota Department of Administration are recent active buyers.

Activity concentrates in Florida and Minnesota, with Texas HHS Commission engagement in exploratory procurement strategy. Recent representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon through authorized wholesalers; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program. The Seminole County contract carries a two-year initial term with one-year renewal option, while MMCAP's contract runs two years for new vendors with optional extensions through June 30, 2028.